Mesoblast, Ltd.

Quick facts

Phase 3 pipeline

• Rexlemestrocel-L + HA Mixture · Regenerative Medicine / Orthopedics
  Rexlemestrocel-L is an allogeneic mesenchymal stem cell therapy combined with hyaluronic acid that promotes tissue repair and reduces inflammation through paracrine signaling and immunomodulation.

Phase 2 pipeline

• Allogeneic Mesenchymal Precursor Cells
• Lumbar Interbody Fusion with Autograft
• Lumbar Interbody Fusion with NeoFuse
• NeoFuse
• Single Dose MPCs Injection

Phase 1 pipeline

• MSB-CAR001 Combined With Hyaluronan

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Mesoblast, Ltd. portfolio CI brief
• Mesoblast, Ltd. pipeline updates RSS